በOhio ለኒውሮብላስቶማ የሚደረጉ ክሊኒካዊ ጥናቶች
ለኒውሮብላስቶማ የሚደረጉ 8 ጥናቶች በOhio ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።
በOhio ውስጥ ያሉ ከተሞች
Official study text (English)
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
- Children's Hospital Medical Center of Akron, Akron
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Rainbow Babies and Childrens Hospital, Cleveland
- እና 4 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 3
እስከ እድሜ 30 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT06172296Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Rainbow Babies and Childrens Hospital, Cleveland
- Cleveland Clinic Foundation, Cleveland
- እና 3 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 3
365 Days – 30 Years · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT03126916Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Cincinnati Children's Hospital Medical Center, Cincinnati
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
12 Months – 30 Years · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT04851119Haploidentical Donor Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed & Refractory Neuroblastoma
- Cincinnati Children's Hospital Medical Center, Cincinnati
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ1 እስከ 39 · ሁሉም ጾታዎች · የተሻሻለው በ24 ኦገስ 2026 · NCT07635056SPEARHEAD-3 Pediatric Study
- Cincinnati Children's Hospital Medical Center, Cincinnati
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ ከ2 እስከ 21 · ሁሉም ጾታዎች · የተሻሻለው በ11 ኦገስ 2026 · NCT05642455NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ1 እስከ 31 · ሁሉም ጾታዎች · የተሻሻለው በ20 ጁላይ 2026 · NCT06450041Neuroblastoma Biology Study
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
31 Days – 99 Years · ሁሉም ጾታዎች · የተሻሻለው በ23 ማርች 2026 · NCT01587300A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
- Nationwide Children's Hospital, Columbus
ተሳታዮችን በመፈለግ ላይደረጃ 2
18 Months – 40 Years · ሁሉም ጾታዎች · የተሻሻለው በ12 ኦገስ 2025 · NCT05135975ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።